Home/Filings/4/0000899243-22-024027
4//SEC Filing

Berry Tamsin 4

Accession 0000899243-22-024027

CIK 0001832038other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:44 PM ET

Size

5.6 KB

Accession

0000899243-22-024027

Insider Transaction Report

Form 4
Period: 2022-06-22
Berry Tamsin
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-22+150,000150,000 total
    Exercise: $3.09Exp: 2032-06-21Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option was granted on June 22, 2022 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the shares subject to the grant vesting in equal monthly installments thereafter, subject to continued service through each vesting date.

Issuer

Adagio Therapeutics, Inc.

CIK 0001832038

Entity typeother

Related Parties

1
  • filerCIK 0001924202

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:44 PM ET
Size
5.6 KB